GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (OTCPK:CMPUY) » Definitions » Financial Strength

CMPUY (CompuGroup Medical SE KgaA) Financial Strength : 4 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is CompuGroup Medical SE KgaA Financial Strength?

CompuGroup Medical SE KgaA has the Financial Strength Rank of 4.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

CompuGroup Medical SE KgaA's Interest Coverage for the quarter that ended in Dec. 2024 was 12.79. CompuGroup Medical SE KgaA's debt to revenue ratio for the quarter that ended in Dec. 2024 was 0.71. As of today, CompuGroup Medical SE KgaA's Altman Z-Score is 1.30.


Competitive Comparison of CompuGroup Medical SE KgaA's Financial Strength

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's Financial Strength Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's Financial Strength distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's Financial Strength falls into.


;
;

CompuGroup Medical SE KgaA Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

CompuGroup Medical SE KgaA's Interest Expense for the months ended in Dec. 2024 was $-3 Mil. Its Operating Income for the months ended in Dec. 2024 was $36 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $865 Mil.

CompuGroup Medical SE KgaA's Interest Coverage for the quarter that ended in Dec. 2024 is

Interest Coverage=-1*Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*36.345/-2.842
=12.79

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

CompuGroup Medical SE KgaA's Debt to Revenue Ratio for the quarter that ended in Dec. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(56.076 + 865.381) / 1292.944
=0.71

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

CompuGroup Medical SE KgaA has a Z-score of 1.30, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of 1.3 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (OTCPK:CMPUY) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

CompuGroup Medical SE KgaA has the Financial Strength Rank of 4.


CompuGroup Medical SE KgaA Financial Strength Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.